SCYNEXIS, Inc. (SCYX) DCF Valuation

SCYNEXIS, Inc. (SCYX) DCF Valoración

US | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ
SCYNEXIS, Inc. (SCYX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

SCYNEXIS, Inc. (SCYX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Descubra el verdadero potencial de Scynexis, Inc. (SCYX) con nuestra calculadora DCF avanzada! Ajuste los supuestos esenciales, explore varios escenarios y evalúe los efectos de los cambios en la valoración de Scynexis, Inc. (SCYX), todo convenientemente dentro de una sola plantilla de Excel.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .1 .0 13.2 5.1 140.1 118.7 100.5 85.1 72.0 61.0
Revenue Growth, % 0 -100 0 -61.32 2652.72 -15.33 -15.33 -15.33 -15.33 -15.33
EBITDA -51.3 -51.1 -31.4 -59.9 73.5 -35.0 -29.7 -25.1 -21.3 -18.0
EBITDA, % -42370.25 100 -238.65 -1176.76 52.43 -29.51 -29.51 -29.51 -29.51 -29.51
Depreciation .3 .3 .6 .8 .8 52.4 44.4 37.6 31.8 26.9
Depreciation, % 235.54 100 4.38 15.97 0.57799 44.19 44.19 44.19 44.19 44.19
EBIT -51.6 -51.5 -32.0 -60.7 72.7 -35.2 -29.8 -25.2 -21.3 -18.1
EBIT, % -42605.79 100 -243.04 -1192.73 51.85 -29.63 -29.63 -29.63 -29.63 -29.63
Total Cash 48.4 93.0 104.5 73.5 74.4 107.5 91.0 77.1 65.3 55.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 2.9 .9 2.1 21.8
Account Receivables, % 0 100 6.54 41.27 15.57
Inventories .0 1.9 .5 .9 .0 28.8 24.3 20.6 17.5 14.8
Inventories, % 0 100 3.52 17.66 0 24.24 24.24 24.24 24.24 24.24
Accounts Payable 7.2 4.6 7.8 5.9 7.1 86.6 73.3 62.0 52.5 44.5
Accounts Payable, % 5931.4 100 59.62 116.62 5.1 72.94 72.94 72.94 72.94 72.94
Capital Expenditure .0 .0 -1.2 .0 .0 -2.2 -1.8 -1.5 -1.3 -1.1
Capital Expenditure, % 0 100 -8.9 -0.17678 0 -1.82 -1.82 -1.82 -1.82 -1.82
Tax Rate, % 0.20542 0.20542 0.20542 0.20542 0.20542 0.20542 0.20542 0.20542 0.20542 0.20542
EBITAT -53.0 -48.7 -29.2 -56.5 72.5 -33.7 -28.5 -24.1 -20.4 -17.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -45.6 -55.7 -23.2 -59.3 55.7 50.3 11.1 9.4 8.0 6.8
WACC, % 13.73 13.47 13.31 13.39 13.72 13.53 13.53 13.53 13.53 13.53
PV UFCF
SUM PV UFCF 67.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 7
Terminal Value 60
Present Terminal Value 32
Enterprise Value 100
Net Debt -19
Equity Value 119
Diluted Shares Outstanding, MM 48
Equity Value Per Share 2.45

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real SCYNEXIS financials.
  • Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effects of your inputs on SCYNEXIS’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive Data: SCYNEXIS, Inc.'s historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Results: Observe SCYNEXIS, Inc.'s intrinsic value recalculating instantly.
  • Visual Data Representation: Dashboard charts illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A sophisticated tool for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based SCYNEXIS, Inc. (SCYX) DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates SCYNEXIS, Inc.'s (SCYX) intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to see how they affect potential valuation outcomes.
  5. Analyze and Decide: Utilize the results to inform your investment or financial analysis decisions.

Why Choose This Calculator for SCYNEXIS, Inc. (SCYX)?

  • All-in-One Solution: Combines DCF, WACC, and comprehensive financial ratio analyses tailored for SCYNEXIS.
  • Flexible Inputs: Modify yellow-highlighted fields to explore different financial scenarios for SCYX.
  • In-Depth Analysis: Automatically computes SCYNEXIS’s intrinsic value and Net Present Value.
  • Integrated Data: Historical and projected data provide reliable starting points for analysis.
  • Expert-Level Tool: Suited for financial analysts, investors, and consultants focusing on SCYNEXIS, Inc. (SCYX).

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling SCYNEXIS, Inc. (SCYX) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for SCYNEXIS, Inc. (SCYX).
  • Consultants: Deliver professional valuation insights on SCYNEXIS, Inc. (SCYX) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like SCYNEXIS, Inc. (SCYX) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to SCYNEXIS, Inc. (SCYX).

What the Template Contains

  • Pre-Filled DCF Model: SCYNEXIS, Inc.’s (SCYX) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital specific to SCYNEXIS.
  • Financial Ratios: Assess SCYNEXIS’s profitability, leverage, and efficiency metrics.
  • Editable Inputs: Modify assumptions such as growth rates, margins, and CAPEX to suit your scenarios.
  • Financial Statements: Annual and quarterly reports to facilitate in-depth analysis of SCYNEXIS.
  • Interactive Dashboard: Effortlessly visualize key valuation metrics and results for SCYNEXIS.

No products were found matching.